NCT00490698
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Carcinoma, Renal Cell
Explore clinical trials studying Carcinoma, Renal Cell. Study availability and eligibility vary by location and protocol.
1,363 public trials
252 recruiting studies
Carcinoma, Renal Cell trial results
NCT00272649
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- UCLA Kidney Cancer Program Los Angeles, California, United States
- Univ. of Colorado Health Science Center - Division of Medical Oncology Aurora, Colorado, United States
- Emory University Atlanta, Georgia, United States
- The Indiana University Cancer Center/IUPUI Indianapolis, Indiana, United States
NCT00005995
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Aeterna Zentaris Québec, Quebec, Canada
Completed
Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer
NCT00101114
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- Southwest Oncology Group San Antonio, Texas, United States
Completed
Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer
NCT00060307
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- Southwest Oncology Group San Antonio, Texas, United States
Completed
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
Completed
RNA-Loaded Dendritic Cell Cancer Vaccine
NCT00087984
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- University of California - Irvine Orange, California, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
- University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
- Princess Margaret Hospital Toronto, Ontario, Canada
Completed
Combination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell Carcinoma
NCT00619268
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Centre Paul Papin Angers, France
- Centre Hospitalier Universitaire de Besançon Besançon, France
- Centre Hospitalier Universitaire de Bordeaux - Hôpital St André Bordeaux, France
- Institut Bergonié Bordeaux, France
NCT00301847
- Conditions
- Adenocarcinoma, Brain Diseases, Brain Neoplasms, +25 more
- Locations
-
- University of Chicago Cancer Research Center Chicago, Illinois, United States
- Decatur Memorial Hospital Cancer Care Institute Decatur, Illinois, United States
- Evanston Northwestern Health Care - Evanston Hospital Evanston, Illinois, United States
- Ingalls Cancer Care Center at Ingalls Memorial Hospital Harvey, Illinois, United States
NCT00005842
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +135 more
- Locations
-
- Brooke Army Medical Center Fort Sam Houston, Texas, United States
- Institute for Drug Development San Antonio, Texas, United States